scholarly journals Pharmacists’ roles in mental healthcare: Past, present and future

2021 ◽  
Vol 19 (3) ◽  
pp. 2545
Author(s):  
Sarira El-den ◽  
Jack C. Collins ◽  
Timothy F. Chen ◽  
Claire L. O’Reilly
Keyword(s):  
Disease Burden ◽  
Healthcare Professionals ◽  
Mental Healthcare ◽  
Mental Illnesses ◽  
Current Evidence ◽  
Multidisciplinary Teams ◽  
Healthcare Team ◽  
Policy Changes ◽  
Significant Disease

Mental illnesses cause significant disease burden globally, with medicines being a major modality of treatment for most mental illnesses. Pharmacists are accessible and trusted healthcare professionals who have an important role in supporting people living with mental illness. This commentary discusses the role of pharmacists in mental healthcare, as part of multidisciplinary teams, the current evidence to support these roles, and the training, remuneration and policy changes needed to recognize these roles and embed pharmacists as core members of the mental healthcare team.

scholarly journals Gluten in pharmaceutical products: a scoping review

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Irene Lizano-Díez ◽  
Eduardo L. Mariño ◽  
Pilar Modamio
Keyword(s):  
Scoping Review ◽  
Healthcare Professionals ◽  
Pharmaceutical Products ◽  
Current Evidence ◽  
Gluten Free ◽  
Scoping Reviews ◽  
The Us ◽  
Wide Variability ◽  
Definition Of

Abstract Background Celiac disease (CD) is one of the most common gluten-related disorders. Although the only effective treatment is a strict gluten-free diet, doubts remain as to whether healthcare professionals take this restriction into consideration when prescribing and dispensing medicines to susceptible patients. This scoping review aimed to find out the current evidence for initiatives that either describe the gluten content of medicines or intend to raise awareness about the risk of prescribing and dispensing gluten-containing medicines in patients with CD and other gluten-related disorders. Methods A scoping review was conducted using three search strategies in PubMed/MEDLINE, TripDatabase and Web of Science in April 2021, following the PRISMA extension for scoping reviews (PRISMA-ScR). References from included articles were also examined. Two researchers screened the articles and results were classified according to their main characteristics and outcomes, which were grouped according to the PCC (Population, Concept and Context) framework. The initiatives described were classified into three targeted processes related to gluten-containing medicines: prescription, dispensation and both prescription and dispensation. Results We identified a total of 3146 records. After the elimination of duplicates, 3062 articles remained and ultimately 13 full texts were included in the narrative synthesis. Most studies were conducted in the US, followed by Canada and Australia, which each published one article. Most strategies were focused on increasing health professional’s knowledge of gluten-containing/gluten-free medications (n = 8), which were basically based on database development from manufacturer data. A wide variability between countries on provided information and labelling of gluten-containing medicines was found. Conclusion Initiatives regarding the presence of gluten in medicines, including, among others, support for prescribers, the definition of the role of pharmacists, and patients’ adherence problems due to incomplete labelling of the medicines, have been continuously developed and adapted to the different needs of patients. However, information is still scarce, and some aspects have not yet been considered, such as effectiveness for the practical use of solutions to support healthcare professionals.

Support by peers in the clinical team in oncology: Perception of the contribution of patient advisors to improve the patient experience.

2020 ◽  
Vol 38 (29_suppl) ◽  
pp. 57-57
Author(s):  
Marie-Pascale Pomey ◽  
Israël Fortin ◽  
Marie-Andrée Côté ◽  
Mado Desforges ◽  
Karine Bouchard ◽  
...  
Keyword(s):  
Healthcare Professionals ◽  
Genetic Test ◽  
Healthcare Team ◽  
Clinical Team ◽  
Educational Support ◽  
Cancer Experience ◽  
Patients Experience ◽  
Support Methods ◽  
The Impact

57 Background: Since 2018, three establishments in Quebec have introduced patient advisors (PA) in their healthcare team in order to improve cancer patients’ experience. These PA, who have had a cancer experience, meet patients undergoing radiotherapy treatments or in oncogenetics for breast cancer on the healthcare site. They conduct consultations to complete the offer of services by bringing emotional, informational, and educational support. Methods: A longitudinal study of multiple cases was completed from January to June 2020. After each accompaniment, the PA filled out a logbook to document the main themes covered and the accompanied patient fill out a survey to evaluate their experience one week after the intervention. A qualitative analysis of the logbook content and descriptive statistics were conducted. The REDCAP platform was used for monitoring the process of data collection and to administer the surveys online. Results: In total, 67 patients were accompanied by 4 PA. 71 logbooks were completed by the PA. The logbooks show that 70.3% of accompaniments took place right before radiotherapy and 63.6% following the results of the genetic test in oncogenetics. 50% of meetings took place in person in the establishment (in a space dedicated to the PA or not) and 45.8% were by phone. The meetings lasted approximately 37 minutes (min: 15 minutes and max: 90 minutes). The majority only met once (93.1 %). The most common themes discussed are: the role of the PA (94.1%), returning to day life (57.6%) and dealing with stress and anxiety (52.2%). 96% of PA felt that they did not encounter any difficulties during the accompaniment. For the accompanied women, the partnership was most beneficial for their experience with the illness (sharing experiences of side-effects, on the impact of the illness on every day life, with their social circle). 79% of patients found that the accompaniment met their needs. 90% of patients estimate that these meetings are complimentary to the healthcare professionals’ interventions. Finally, 89.5% of accompanied patients think that it would be very important to develop these types of meetings on a larger scale. Concerning the adaptation of spaces for the meetings, 26.3% are very satisfied and 26.3% are rather satisfied (probably an area for improvement). Conclusions: Overall, the partnerships seem to answer the needs of the accompanied patients and the PA can share their experience inside the clinical team.

scholarly journals Understanding and perceptions of gout: an interdisciplinary assessment among patients, physicians and pharmacists in Italy

Reumatismo ◽  
2020 ◽  
Vol 72 (1) ◽  
pp. 31-43 ◽  
Author(s):  
L. Punzi ◽  
G. Medea
Keyword(s):  
Uric Acid ◽  
Genetic Factors ◽  
Healthcare Professionals ◽  
Treatment Strategies ◽  
Multidisciplinary Teams ◽  
Therapeutic Approaches ◽  
Cross Sectional ◽  
Interdisciplinary Assessment ◽  
The Many

The objective was to assess knowledge and therapeutic approaches to the management of gout among healthcare professionals and people with/without gout, in Italy. This was a cross-sectional internet-based survey targeting general practitioners (GPs), specialists, pharmacists, and people with/without gout. Between December 2017 and March 2018, participants completed questionnaires on epidemiology, cause/risk factors, therapy objectives and management/treatment strategies to improve outcomes. Overall, 3184 people completed the survey: 699 GPs, 426 specialists, 655 pharmacists and 1404 subjects from the general population: 126 (9.0%) with and 1278 (91.0%) without gout. Notably, less than half of GPs, specialists and people without gout confirmed the published 1% prevalence of gout in Italy. Lifestyle was acknowledged as the main risk factor for gout by nearly 50% of specialists and GPs, while only 13.8% and 12.4%, respectively, considered the role of genetic factors. Uric acid overproduction was deemed as the cause of gout by 60% of GPs and specialists, whereas insufficient excretion by only 30%. Fewer than half of patients were aware that gout permanently damages joints, and even fewer of the renal and cardiovascular implications (19.4% and 12%, respectively); moreover, most people without gout replied that their doctor had never talked with them about uric acid and its correlation with gout development. Finally, GPs were divided on uric acid target levels (48.3% said <6 mg/dL and 18.9% <7 mg/dL). Despite major advances in the knowledge of physiopathological mechanisms of gout, the results of our survey highlight the many treatment and knowledge gaps in its management. Cooperation between multidisciplinary teams is required to break down barriers and ensure optimal treatment with effective and innovative agents of this ever-increasing debilitating condition.

scholarly journals Surgical Management of the Forefoot in Patients with Rheumatoid Arthritis - A Review Article

2015 ◽  
Vol 9 (1) ◽  
pp. 78-83 ◽  
Author(s):  
W.J. Nash ◽  
S. Al-Nammari ◽  
W.S. Khan ◽  
I.P. Pengas
Keyword(s):  
Rheumatoid Arthritis ◽  
Surgical Management ◽  
Medical Therapy ◽  
Multidisciplinary Team ◽  
Disease Burden ◽  
Review Article ◽  
Foot And Ankle ◽  
Significant Disease

Foot and ankle pathologies cause a significant disease burden on rheumatoid patients. Forefoot pathologies causes pain, callosities and possibly ulceration, and can cause problems with footwear. Forefoot correction in rheumatoid patients has historically comprised of excision of diseased joints. While satisfaction was high with this procedure, complications, changing expectations and improvement in medical therapy have raised expectation of patients, physicians and surgeons alike. This review assesses the role of joint preserving osteotomies and arthrodesis, as well as associated complications. It also describes the role of the multidisciplinary team in the management of these patients.

scholarly journals Communities of practice: acknowledging vulnerability to improve resilience in healthcare teams

2020 ◽  
pp. medethics-2019-105865 ◽  
Author(s):  
Janet Delgado ◽  
Janet de Groot ◽  
Graham McCaffrey ◽  
Gina Dimitropoulos ◽  
Kathleen C Sitter ◽  
...  
Keyword(s):  
Communities Of Practice ◽  
Compassion Fatigue ◽  
Healthcare Professionals ◽  
Shared Knowledge ◽  
Healthcare Team ◽  
Self Awareness ◽  
Professional Lives ◽  
Healthy Work ◽  
Inherent Vulnerability

The majority of healthcare professionals regularly witness fragility, suffering, pain and death in their professional lives. Such experiences may increase the risk of burnout and compassion fatigue, especially if they are without self-awareness and a healthy work environment. Acquiring a deeper understanding of vulnerability inherent to their professional work will be of crucial importance to face these risks. From a relational ethics perspective, the role of the team is critical in the development of professional values which can help to cope with the inherent vulnerability of healthcare professionals. The focus of this paper is the role of Communities of Practice as a source of resilience, since they can create a reflective space for recognising and sharing their experiences of vulnerability that arises as part of their work. This shared knowledge can be a source of strength while simultaneously increasing the confidence and resilience of the healthcare team.

scholarly journals Neuropsychiatric symptoms in dementia

2016 ◽  
Author(s):  
Valeria Manera ◽  
Julie Brousse ◽  
Pierre Foulon ◽  
Audrey Deudon ◽  
Elsa Leone ◽  
...  
Keyword(s):  
Nursing Home ◽  
Nursing Homes ◽  
Healthcare Professionals ◽  
Neuropsychiatric Symptoms ◽  
Treatment Success ◽  
Critical Factor ◽  
Home Healthcare ◽  
Current Evidence ◽  
People With Dementia

Neuropsychiatric symptoms (NPS) are very common in people with dementia-related disorders, and are responsible for a large share of the suffering of patients and caregivers. Current evidence suggests that non-pharmacological treatments are promising solutions to NPS. However, a critical factor in the treatment success is represented by the involvement of professional and family caregivers. Here we briefly present “No panic in the nursing home”, an educational “serious game” designed for healthcare professionals working in nursing homes. Based on an educational program previously designed by our group, “No Panic in the Nursing Home”  teaches professional caregivers how to deal with NPS of dementia. The player takes the role of a nursing home nurse, and is confronted with practical situations in which he/she needs to decide how to behave. Results collected in three nursing homes suggest that the game is considered as very interesting by nursing home healthcare professionals, even by persons with no previous experience with videogames.

scholarly journals Safeguarding vulnerable adults: the psychiatrist's roles and responsibilities

2013 ◽  
Vol 19 (6) ◽  
pp. 437-445 ◽  
Author(s):  
Richard Hodgson ◽  
Jude Rheade
Keyword(s):  
Healthcare Professionals ◽  
Good Practice ◽  
Mental Healthcare ◽  
Legal Protection ◽  
Roles And Responsibilities ◽  
Legal Challenge ◽  
The Uk ◽  
Vulnerable Adults

SummaryFor decades society has recognised that children are vulnerable and so it has sought to protect them. However, similar legal protection for adults who may be equally vulnerable has been neglected. The incremental introduction of legislation and reports in the UK, along with guidelines on good practice, now afford adults safeguarding procedures similar to those for children. This article offers a practical overview of these developments. In addition, it highlights some of the dilemmas that face practitioners in this evolving arena, as legislation and policy do not anticipate the diverse scenarios in which mental healthcare professionals may be involved. Decisions made can be subject to legal challenge, so it is important that psychiatrists understand their role as well as the role of their organisation in this complex area.

Nature and scope of medical social work in healthcare setting in Pakistan

2021 ◽  
Vol 71 (10) ◽  
pp. 2385-2390
Author(s):  
Ibad Ullah Sajid ◽  
Aqib Shehzad Alvi ◽  
Irfan Nawaz
Keyword(s):  
Social Work ◽  
Social Workers ◽  
Healthcare Professionals ◽  
Healthcare Setting ◽  
Professional Status ◽  
Multidisciplinary Teams ◽  
Medical Social Work ◽  
Healthcare Administrators ◽  
The One

A sick person’s needs are hardly ever simple rather these are complicated and multifold which require several kinds of assistance, simultaneously. Medicine is the one while the Medical Social Work (MSW) is another way. Social Work discipline emerged in earlier 20th century but in Pakistan, it has been started in 1953. The role of Social Work in healthcare setting is exclusively unique. Social Workers as a part of multidisciplinary teams are dealing with the multidimensional issues of the patients. In Pakistan, the MSW seems failed to achieve a mature professional status and it is still blurred in terms of skills and services. The significance of Social Work services is vague to healthcare administrators and even healthcare professionals. The role of social workers in healthcare setting is limited. Continuous...

scholarly journals Healthcare Professionals’ and Users’ Experiences of Intersectoral Care between Hospital and Community Mental Healthcare

2020 ◽  
Vol 17 (18) ◽  
pp. 6510 ◽  
Author(s):  
Kim Jørgensen ◽  
Mette Bonde Dahl ◽  
Jesper Frederiksen
Keyword(s):  
Healthcare Professionals ◽  
Mental Healthcare ◽  
Mental Illnesses ◽  
Focus Group Interviews ◽  
User Perspective ◽  
Recovery Processes ◽  
Professional Perspective ◽  
Hermeneutic Approach ◽  
Group Interviews ◽  
Accurate Reporting

This paper explores healthcare professionals’ and users’ experience of coherent intersectoral care between hospital mental healthcare and community mental healthcare. A total of 20 healthcare professionals, primarily nurses, and 14 users with a range of mental illnesses participated in nine focus group interviews (FGIs). Participants were encouraged in the FGIs to reflect upon their experience of coherency in intersectoral care. The analysis of FGIs was informed by a phenomenological-hermeneutic approach in a research group from 2016–2019. The Consolidated Criteria for Reporting Qualitative Research checklist was used as a guideline to ensure complete and accurate reporting of the study. The analysis led to the generation of several themes from a professional perspective and from a user perspective, addressed barriers to coherent intersectoral care. The healthcare professionals experienced barriers such as a lack of common language and knowledge of partners. The users did not feel involved and lacked coherence in their recovery processes and, as such, intersectoral care was often experienced as being lost in a maze.

scholarly journals Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics

2020 ◽  
Vol 56 (5) ◽  
pp. 2000260
Author(s):  
Celeste M. Porsbjerg ◽  
Asger Sverrild ◽  
Clare M. Lloyd ◽  
Andrew N. Menzies-Gow ◽  
Elisabeth H. Bel
Keyword(s):  
Airway Epithelium ◽  
Disease Burden ◽  
Potential Role ◽  
Eosinophilic Inflammation ◽  
Fractional Exhaled Nitric Oxide ◽  
Mucus Production ◽  
Significant Disease ◽  
Severe Type

Monoclonal antibody therapies have significantly improved treatment outcomes for patients with severe asthma; however, a significant disease burden remains. Available biologic treatments, including anti-immunoglobulin (Ig)E, anti-interleukin (IL)-5, anti-IL-5Rα and anti-IL-4Rα, reduce exacerbation rates in study populations by approximately 50% only. Furthermore, there are currently no effective treatments for patients with severe, type 2-low asthma. Existing biologics target immunological pathways that are downstream in the type 2 inflammatory cascade, which may explain why exacerbations are only partly abrogated. For example, type 2 airway inflammation results from several inflammatory signals in addition to IL-5. Clinically, this can be observed in how fractional exhaled nitric oxide (FeNO), which is driven by IL-13, may remain unchanged during anti-IL-5 treatment despite reduction in eosinophils, and how eosinophils may remain unchanged during anti-IL-4Rα treatment despite reduction in FeNO. The broad inflammatory response involving cytokines including IL-4, IL-5 and IL-13 that ultimately results in the classic features of exacerbations (eosinophilic inflammation, mucus production and bronchospasm) is initiated by release of “alarmins” thymic stromal lymphopoietin (TSLP), IL-33 and IL-25 from the airway epithelium in response to triggers. The central, upstream role of these epithelial cytokines has identified them as strong potential therapeutic targets to prevent exacerbations and improve lung function in patients with type 2-high and type 2-low asthma. This article describes the effects of alarmins and discusses the potential role of anti-alarmins in the context of existing biologics. Clinical phenotypes of patients who may benefit from these treatments are also discussed, including how biomarkers may help identify potential responders.

Sign in / Sign up

Export Citation Format

Share Document